On the other hand, high SOCS3 expression among the low SOCS1 expressing HCC cases predicted a shorter progression-free survival, suggesting a faster disease progression in the SOCS1-low/SOCS3-high patient group (Figure 4g). This evidence concerns the gene SOCS1 and hepatocellular carcinoma.